ConditionDigestive system

Nonalcoholic Fatty Liver Disease and NASH

Nonalcoholic fatty liver disease (NAFLD) is fat build-up in the liver in people who drink little or no alcohol, linked to excess weight, type 2 diabetes, high blood pressure and high cholesterol. It was renamed metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023. In a minority, the fat causes inflammation and liver cell damage, called NASH (now MASH), which can lead to scarring, cirrhosis and liver cancer. It usually causes no symptoms. Losing 7% to 10% of body weight can reverse much of the damage.

Also called: NAFLD, NASH, MASLD, MASH, fatty liver disease, nonalcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease

At a glance

What it is
Excess liver fat linked to metabolic risk factors, not heavy alcohol use.
Stages
Simple fatty liver, steatohepatitis (NASH/MASH), fibrosis, cirrhosis.
How common
About 1 in 3 adults; a smaller share have NASH.
Symptoms
Usually none; sometimes tiredness or upper right belly discomfort.
Tests
Liver blood tests, FIB-4 score, ultrasound, FibroScan or other elastography.
Treatment
Weight loss, exercise, diabetes and cholesterol control; resmetirom or other medicines for NASH with fibrosis.

When to get help

Call 911 or go to the ER

  • Vomiting blood or black stools in someone with liver disease
  • Confusion, extreme drowsiness or a swollen, tense belly with fever

See a doctor within a day or two

  • Yellowing of the skin or eyes
  • Rapidly increasing belly swelling or leg swelling
  • Easy bruising or bleeding

Book a routine appointment

  • Fatty liver found on a scan or abnormal liver blood tests
  • Type 2 diabetes or obesity, to assess liver fibrosis risk
  • Persistent tiredness with upper right belly discomfort

What happens in fatty liver disease

When the body takes in more energy than it uses, and especially when cells become resistant to insulin, fat accumulates inside liver cells. More than 5% fat in the liver is defined as fatty liver (steatosis).

StageWhat is happeningReversible?
Simple steatosis (MASL)Fat in liver cells without significant inflammationYes
Steatohepatitis (NASH/MASH)Fat plus inflammation and liver cell injuryYes, with weight loss
FibrosisScar tissue forms; graded F1 to F4Early stages can improve
CirrhosisExtensive scarring; liver function can failLargely irreversible

Fibrosis stage is the best predictor of future liver problems. Most people with fatty liver never develop cirrhosis, but because so many people have it, MASLD is becoming a leading cause of cirrhosis, liver cancer and liver transplantation.

The name change

In 2023, international liver societies renamed NAFLD to MASLD and NASH to MASH, emphasizing the role of metabolic risk factors and avoiding stigmatizing terms. Nearly everyone with NAFLD meets the new definition. People with MASLD who also drink moderate amounts of alcohol are classed as MetALD.

Risk factors

  • obesity, especially fat around the waist
  • type 2 diabetes and prediabetes
  • high blood pressure
  • high triglycerides and low HDL cholesterol
  • metabolic syndrome
  • sleep apnea, polycystic ovary syndrome, underactive thyroid
  • certain genetic variants (such as PNPLA3)
  • Hispanic ancestry is associated with higher rates in the US

Lean people can also develop fatty liver, especially with insulin resistance.

Symptoms

Most people have no symptoms. Possible symptoms include:

  • tiredness
  • dull ache or fullness in the upper right belly
  • an enlarged liver found on examination

Advanced fibrosis or cirrhosis can cause jaundice, belly swelling (ascites), leg swelling, easy bruising, confusion and vomiting blood.

Diagnosis

  1. Blood tests: liver enzymes (ALT, AST) may be raised or normal; also blood sugar, cholesterol and tests to rule out other liver diseases (hepatitis B and C, iron overload, autoimmune).
  2. Imaging: ultrasound commonly shows fatty liver.
  3. FIB-4 score: a calculation using age, liver enzymes and platelet count to estimate fibrosis risk; recommended for people with risk factors.
  4. Elastography: FibroScan (vibration-controlled transient elastography) or MR elastography measures liver stiffness and fat.
  5. Liver biopsy: only when the diagnosis or stage is uncertain.

Treatment

Lifestyle (the foundation)

  • Weight loss: losing 5% of body weight reduces liver fat; 7% to 10% can resolve NASH; 10% or more can improve fibrosis.
  • Diet: a Mediterranean-style diet, fewer sugary drinks and refined carbohydrates, less ultra-processed food.
  • Exercise: at least 150 minutes of moderate activity a week; resistance training helps even without weight loss.
  • Alcohol: limit or avoid, especially with fibrosis.
  • Coffee: regular coffee consumption is associated with lower fibrosis risk.

Medicines

  • Resmetirom: the first medicine approved by the FDA (2024) specifically for MASH with moderate to advanced fibrosis, used with diet and exercise.
  • GLP-1 receptor agonists such as semaglutide: help weight loss and improve MASH; semaglutide has also been approved for MASH with fibrosis.
  • Pioglitazone: improves NASH in people with or without diabetes; may cause weight gain.
  • Vitamin E: may help some people without diabetes with biopsy-proven NASH; long-term risks are debated.
  • Statins: safe and recommended to reduce heart disease risk, the leading cause of death in people with fatty liver.

Bariatric surgery

For people with severe obesity, weight-loss surgery often resolves NASH and can improve fibrosis.

Cirrhosis care

People with cirrhosis need ultrasound screening for liver cancer every 6 months, monitoring for varices, and evaluation for transplant if the liver fails.

Complications

  • cirrhosis and liver failure
  • liver cancer, sometimes even before cirrhosis
  • heart disease and stroke, which are the most common causes of death
  • type 2 diabetes and chronic kidney disease

Frequently asked questions

What is the difference between NAFLD and NASH?

NAFLD is the overall condition of excess fat in the liver. NASH is a more serious form where the fat causes inflammation and liver cell damage, which can lead to scarring and cirrhosis. They have been renamed MASLD and MASH.

Can fatty liver disease be reversed?

Yes, often. Losing 7% to 10% of body weight through diet and exercise can reduce liver fat, resolve inflammation and even improve early scarring. Cirrhosis is much harder to reverse, so early action matters.

What are the symptoms of fatty liver?

Most people have no symptoms. Some notice tiredness or a dull ache in the upper right belly. Symptoms of advanced disease, such as yellow skin, swelling of the belly or legs, and confusion, appear only when significant scarring has developed.

What is the best diet for fatty liver?

A Mediterranean-style diet rich in vegetables, fruit, whole grains, legumes, fish, olive oil and nuts, with fewer sugary drinks, refined carbohydrates and processed foods, is recommended. Reducing calories to achieve weight loss is the key goal.

Is fatty liver disease dangerous?

Simple fatty liver usually is not, but it signals metabolic problems that raise heart disease risk. In a minority, it progresses to NASH, fibrosis, cirrhosis and liver cancer. Testing for fibrosis helps identify who needs closer monitoring.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Association for the Study of Liver Diseases (AASLD): Practice guidance on the clinical assessment and management of NAFLD (2023)
  • Multisociety Delphi consensus: A new nomenclature for steatotic liver disease (2023)
  • NIDDK: Nonalcoholic fatty liver disease and NASH
  • American Gastroenterological Association: Clinical care pathway for risk stratification and management of NAFLD
  • US Food and Drug Administration: Approval of resmetirom for NASH with liver scarring (2024)